Found 5 matching trials
Natural Killer Cell (CYNK-001) Infusions in Adults With Multiple Myeloma
PHASE1This study will find the maximum tolerated dose (MTD) of CYNK-001 which con...
Location
Colorado Blood Cancer Institute
CYNK-001 IV and IC in Combination With IL2 in Surgical Eligible Recurrent GBM With IDH-1 Wild Type
PHASE1A Phase 1/2a Open Label Multicenter, Non-Randomized, Trial to Assess the Sa...
Location
Multiple Locations
Natural Killer Cell (CYNK-001) Infusions in Adults With COVID-19
PHASE1This study is a Phase 1 / 2 trial to determine the safety and efficacy of C...
Natural Killer Cell (CYNK-001) IV Infusion or IT Administration in Adults With Recurrent GBM
PHASE1This study will find the maximum safe dose (MSD) or maximum tolerated dose ...
Location
The Univeristy of Texas MD ANderson Cancer Center
Natural Killer Cell (CYNK-001) Infusions in Adults with AML
PHASE1This study will find the maximum tolerated dose or the maximum planned dose...
Location
Colorado Blood Cancer Institute